Abstract
Doxorubicin is one of the most potent anti-tumor agents generally used in the treatment of bone cancer. A simple and sensitive HPLC method was developed and validated for the assay of doxorubicin. The method used a C 18 Luna microbore column (50x1 mm) with a fluorescent detector (505 nm Ex. and 550 nm Em.). The mobile phase consisted of water-acetonitrile-acetic acid (80:19:1, v/v/v, pH 3.0) and the flow rate was 0.1 ml min -1. Daunomycin was used as the internal standard. This isocratic system required a 10-min run-time, giving a detection limit of 0.02 ng (0.035 pmol per injection). Standard curves were linear over the concentration range of 0.01-0.1 μg ml -1. Relative standard deviations (R.S.D.) for the within-day, day-to-day precision, and the accuracy measurement for the assay were less than 4.0, 3.2, and 4.1%, respectively. This HPLC method was used to study the in vitro release characteristics of doxorubicin from implantable drug delivery system. Copyright (C) 1999 Elsevier Science B.V.
| Original language | English |
|---|---|
| Pages (from-to) | 543-548 |
| Number of pages | 6 |
| Journal | Journal of Pharmaceutical and Biomedical Analysis |
| Volume | 20 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jul 1999 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Analytical Chemistry
- Pharmaceutical Science
Cite this
A simple HPLC method using a microbore column for the analysis of doxorubicin. / Zhao, Ping; Dash, Alekha K.
In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 20, No. 3, 07.1999, p. 543-548.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A simple HPLC method using a microbore column for the analysis of doxorubicin
AU - Zhao, Ping
AU - Dash, Alekha K.
PY - 1999/7
Y1 - 1999/7
N2 - Doxorubicin is one of the most potent anti-tumor agents generally used in the treatment of bone cancer. A simple and sensitive HPLC method was developed and validated for the assay of doxorubicin. The method used a C 18 Luna microbore column (50x1 mm) with a fluorescent detector (505 nm Ex. and 550 nm Em.). The mobile phase consisted of water-acetonitrile-acetic acid (80:19:1, v/v/v, pH 3.0) and the flow rate was 0.1 ml min -1. Daunomycin was used as the internal standard. This isocratic system required a 10-min run-time, giving a detection limit of 0.02 ng (0.035 pmol per injection). Standard curves were linear over the concentration range of 0.01-0.1 μg ml -1. Relative standard deviations (R.S.D.) for the within-day, day-to-day precision, and the accuracy measurement for the assay were less than 4.0, 3.2, and 4.1%, respectively. This HPLC method was used to study the in vitro release characteristics of doxorubicin from implantable drug delivery system. Copyright (C) 1999 Elsevier Science B.V.
AB - Doxorubicin is one of the most potent anti-tumor agents generally used in the treatment of bone cancer. A simple and sensitive HPLC method was developed and validated for the assay of doxorubicin. The method used a C 18 Luna microbore column (50x1 mm) with a fluorescent detector (505 nm Ex. and 550 nm Em.). The mobile phase consisted of water-acetonitrile-acetic acid (80:19:1, v/v/v, pH 3.0) and the flow rate was 0.1 ml min -1. Daunomycin was used as the internal standard. This isocratic system required a 10-min run-time, giving a detection limit of 0.02 ng (0.035 pmol per injection). Standard curves were linear over the concentration range of 0.01-0.1 μg ml -1. Relative standard deviations (R.S.D.) for the within-day, day-to-day precision, and the accuracy measurement for the assay were less than 4.0, 3.2, and 4.1%, respectively. This HPLC method was used to study the in vitro release characteristics of doxorubicin from implantable drug delivery system. Copyright (C) 1999 Elsevier Science B.V.
UR - http://www.scopus.com/inward/record.url?scp=0032982449&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032982449&partnerID=8YFLogxK
U2 - 10.1016/S0731-7085(99)00070-9
DO - 10.1016/S0731-7085(99)00070-9
M3 - Article
C2 - 10701970
AN - SCOPUS:0032982449
VL - 20
SP - 543
EP - 548
JO - Journal of Pharmaceutical and Biomedical Analysis
JF - Journal of Pharmaceutical and Biomedical Analysis
SN - 0731-7085
IS - 3
ER -